Gyros Protein Technologies

Activities: Analysis Pharmaceutical

Trending Articles

  1. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  4. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
  5. ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Research & Development

Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency

Partnership complements Gyros’ PurePep EasyClean technology offering with an automated solution for advanced discovery process
Manufacturing

Gyros Protein Technologies introduces updated peptide synthesiser

The device introduces real-time flow technology, a non-invasive method designed to continually monitor the flow rate of fluids within the system
Manufacturing

Gyros Protein Technologies introduces Gyrolab AAV9 Titer kit

The kit is designed to support AAV-based CGT production
Finance

Gyros Protein Technologies and Cygnus expand collaboration

The extension of the collaboration follows the launch of the ready-to-use Gyrolab CHO HCP and <i>E. coli</i> HCP kits, developed through a licensing and supply agreement with Cygnus
Manufacturing

Mesa Labs acquires Gyros Protein Technologies

The US-based quality control instrument supplier has acquired the Swedish protein synthesis solutions provider to begin its push into biopharmaceutical development
Manufacturing

Gyros Protein Technologies introduces lentivirus titre kit

Ready-to-use kit enabled lentivirus titre determinations during the manufacture of lentivirus vectors
Manufacturing

Gyros Protein Technologies debuts test for impurities in E. coli systems

New product is a host cell protein (HCP) kit for automated impurity analysis of biotherapeutics expressed in <i>E. coli</i> systems
Subscribe now